secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beyond Air, Inc. (XAIR)
CIK:        0001641631
Form:       8-K
Filed at:   2026-07-31T12:30:14+00:00
Accession:  0001493152-26-035550
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beyond Air raises up to $30.1M in private placement for LungFit PH launch
-------------------------------------------------------------------------

- Gross proceeds of $10.2M upfront from 167,011 shares and pre-funded warrants; up to $30.1M if all warrants exercised.
- Series A warrants (1.8M shares) expire 1 year or 45 days after FDA approval of LungFit PH II; Series B warrants (1.8M shares) expire 5 years.
- CEO Robert Goodman and CFO Dan Moorhead participate at $5.76/share; institutional investors at $5.66/share.
- Net proceeds for working capital and general corporate purposes; closing expected July 31, 2026.
- Cantor Fitzgerald leads placement agents; registration statement to be filed within 15 days of closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641631/000149315226035550/0001493152-26-035550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641631/000149315226035550/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-035550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer